A contemporary estimate of total mortality and cardiovascular disease risk in young adults with type 1 diabetes: The pittsburgh epidemiology of diabetes complications study

Diabetes Care

Volumn 39, Issue 12, 2016, Pages 2296-2303

  Miller, Rachel G ^a   Mahajan, Hemant D ^a   Costacou, Tina ^a   Sekikawa, Akira ^a   Anderson, Stewart J ^a   Orchard, Trevor J ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; SEX DIFFERENCE; STANDARDIZED MORTALITY RATIO; UNITED STATES; AGED; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPLICATION; DIABETES COMPLICATIONS; FOLLOW UP; MIDDLE AGED; PENNSYLVANIA; RISK FACTOR; YOUNG ADULT;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; PENNSYLVANIA; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85006176212     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-1162     Document Type: Conference Paper

References (37)

1. Morgan E, Cardwell CR, Black CJ, McCance DR, Patterson CC. Excess mortality in Type 1 diabetes diagnosed in childhood and adolescence: A systematic review of population-based cohorts. Acta Diabetol 2015;52:801-807
2. Huxley RR, Peters SAE,Mishra GD,Woodward M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: A systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015;3:198-206
3. Livingstone SJ, Looker HC, Hothersall EJ, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 2012;9:e1001321
4. Lind M, Svensson A-M, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2014;371:1972-1982
5. Harding JL, Shaw JE, Peeters A, Davidson S, Magliano DJ. Age-specific trends from 2000-2011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: A cohort study of more than one million people. Diabetes Care 2016;39:1018-1026
6. Orchard TJ, Nathan DM, Zinman B, et al.; Writing Group for the DCCT/EDIC Research Group. Association between 7 years of intensive insulin treatment of T1DM and long-term mortality. JAMA 2015;313:45-53
7. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care 2006;29:2528-2538
8. Dorman JS, Laporte RE, Kuller LH, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 1984;33:271-276
9. Krolewski AS, Kosinski EJ,Warram JH, et al.Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-755
10. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991;81:1158-1162
11. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with longstanding childhood-onset type 1 diabetes. Diabetes 2010;59:3216-3222
12. The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Care 2016; 39:686-693
13. Stone NJ, Robinson JG, Lichtenstein AH, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(Suppl. 2):S1-S45
14. Wagener DK, Sacks JM, LaPorte RE, Macgregor JM. The Pittsburgh study of insulindependent diabetes mellitus: risk for diabetes among relatives of IDDM. Diabetes 1982;31: 136-144
15. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: The Pittsburgh Epidemiology of Diabetes Complications Study Experience. Diabetes 2006;55:1463-1469
16. Diabetes Epidemiology Research InternationalMortality Study Group. International evaluation of cause-specific mortality and IDDM. Diabetes Care 1991;14:55-60
17. Prince CT, Becker DJ, Costacou T, Miller RG, Orchard TJ. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia 2007;50:2280-2288
18. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-482
19. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475
20. Warnick GR, Albers JJ. Heparin-Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin Chem 1978;24:900-904
21. Lipid Research Clinics Program. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Vol. 1. Washington, DC, National Institutes of Health, Department of Health, U.S. Govt. Printing Office; 1974
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
23. Hypertension Detection and Follow-up Program Cooperative Group. The hypertension Detection and Follow-up program. Prev Med 1976;5: 207-215
24. Ellis D, Coonrod BA, Dorman JS, et al. Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis 1989;13:321-328
25. Dean A, Sullivan K, Soe M. OpenEpi: Open source epidemiologic statistics for public health [Internet], 2015. Available from http://www.openepi.com/Menu/OE-Menu.htm. Accessed 4 September 2016
26. Patterson CC, Dahlquist G, Harjutsalo V, et al. Early mortality in EURODIAB populationbased cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 2007;50: 2439-2442
27. Collado-Mesa F, Díaz-Díaz O, Melián-Torres R, Suárez-Pérez R, Vera-González M, Aldana-Padilla D. Mortality of childhood-onset IDDM patients: A cohort study in Havana City Province, Cuba. Diabetes Care 1997;20:1237-1241
28. Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: The Allegheny County Type 1 Diabetes Registry. Diabetes Care 2010;33:2573-2579
29. Petrie D, Lung TW, Rawshani A, et al. Recent trends in life expectancy for people with T1DM in Sweden. Diabetologia 2016;59: 1167-1176
30. Harding JL, Shaw JE, Peeters A, Guiver T, Davidson S, Magliano DJ. Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997-2010. Diabetes Care 2014; 37:2579-2586
31. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332: 73-78
32. Colhoun HM, Rubens MB, Underwood SR, Fuller JH. The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol 2000;36: 2160-2167
33. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 1996; 16:720-726
34. National Collaborating Centre for Chronic Conditions. Type 1 Diabetes in Adults: National Clinical Guidelines for Diagnosis and Management in Primary and Secondary Care. London, Royal College of Physicians, 2004, p. 73-87
35. Thanassoulis G, Williams K, Altobelli KK, Pencina MJ, Cannon CP, Sniderman AD. Individualized statin benefit for determining statin eligibility in the primary prevention of cardiovascular disease. Circulation 2016;133:1574-1581. DOI: 10.1161/CIRCULATIONAHA.115.018383
36. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes 2016;65:1370-1379
37. Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ. Improvements in the life expectancy of type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study Cohort. Diabetes 2012;61:2987-2992